NEW YORK, Nov. 22, 2013 /PRNewswire/ -- Effective today Empire Asset Management Company, a FINRA member (143007) terminated coverage of TrovaGene (NASDAQ:TROV). We are discontinuing coverage of TrovaGene Inc because the analyst covering the company is no longer associated with the firm. Shares of TrovaGene have been rated a buy since May 6, 2013. Investors should no longer rely on Empire Asset Management research for an investment recommendation on TrovaGene.
TrovaGene Inc closed on Thursday, November 21st at $5.51
SOURCE Empire Asset Management Company